Skip to main content

Table 2 Clinical outcomes of pneumonia patients caused by K. pneumoniae

From: Clinical characteristics of patients with pneumonia caused by Klebsiella pneumoniae in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains: a retrospective study

Variable

CAP (n = 68)

HCAP (n = 74)

HAP (n = 134)

p value

CAP vs. HCAP

HCAP vs. HAP

CAP vs. HAP

Appropriate empirical

antimicrobial therapy

64 (94.1)

63 (85.1)

97 (72.4)

0.104

0.037

< 0.001

Appropriate definite

antimicrobial therapy

61 (89.7)

62 (83.8)

101 (75.4)

0.300

0.158

0.016

Length of stay after pneumonia, median (IQR), days

23.0 (12.5–40.0)

23.5

(10.8–41)

16.0

(6.0–39.3)

0.859

0.126

0.157

Septic shock when pneumonia

20 (29.4)

33 (44.6)

33 (24.6)

0.062

0.003

0.465

Respiratory failure requiring mechanical ventilation

32 (47.1)

27 (36.5)

27 (20.1)

0.202

0.010

0.001

Mortality

 Early mortality (≤48 h)

5 (7.4)

9 (12.2)

20 (14.9)

0.337

0.582

0.122

 28-day mortality

19 (27.9)

22 (29.7)

53 (39.6)

0.814

0.158

0.103

 In-hospital mortality

33 (33.8)

31 (41.9)

65 (48.5)

0.322

0.360

0.047

  1. Data are presented as number (%) of patients, unless stated otherwise
  2. IQR interquartile range, ICU intensive care unit